Zobrazeno 1 - 10
of 158
pro vyhledávání: '"Neal Dunlap"'
Autor:
Abbas Rattani, Jeremy Gaskins, Grant McKenzie, Virginia Kate Scharf, Kristy Broman, Maria Pisu, Ashley Holder, Neal Dunlap, David Schwartz, Mehran B. Yusuf
Publikováno v:
Cancers, Vol 14, Iss 20, p 5059 (2022)
Merkel Cell Carcinoma (MCC) is a rare cancer most commonly affecting White patients; less is known for Black patients. We aim to report presentation, treatment, and quality of registry data by race with a secondary endpoint of overall survival. We co
Externí odkaz:
https://doaj.org/article/60f0d37a72064d14b8ed02e37b8318d9
Autor:
Trisha Wise-Draper, Diana Bell, Roman Jandarov, Shuchi Gulati, Maura Gillison, Vinita Takiar, Sarah Palackdharry, Francis Worden, Matthew Old, John Kaczmar, Neal Dunlap, Benjamin Hinrichs, Yash Patil, Muhammad Kashif Riaz, Layne Weatherford, Aubrey Hamilton, Sheena Lanverman, Michelle Mierzwa, Keith Casper, Jonathan Mark, Alice Tang, Chad Zender, Ann Gillenwater, Mario Medvedovich, J Jack Lee
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/c8ca5e636a384d40ae1ebb2c7416d267
Autor:
Mehran Behruj Yusuf, Grant McKenzie, Abbas Rattani, Paul Tennant, Jeffrey Bumpous, Donald Miller, Neal Dunlap
Publikováno v:
Cancers, Vol 13, Iss 14, p 3506 (2021)
Merkel cell carcinoma (MCC) is a rare, cutaneous neuroendocrine malignancy with increasing incidence. The skin of the head and neck is a common subsite for MCC with distinctions in management from other anatomic areas. Given the rapid pace of develop
Externí odkaz:
https://doaj.org/article/fc4f3918fd0a4fa3a7c2a17d4c02db12
Autor:
Paul Tennant, Zafrulla Khan, Leonid B. Reshko, Jeffrey M. Bumpous, Craig L. Silverman, Neal Dunlap, Keith Sowards, Jeremy Gaskins
Publikováno v:
Contemporary Oncology
Introduction There are insufficient data on surface mold brachytherapy (SMB) in treating oral cancers. We reviewed our institutional experience to investigate the efficacy and toxicity of this treatment modality. Material and methods We retrospective
Autor:
Eric Lamarre, Howard Liu, Matthew Schymick, Farzan Siddiqui, Sandro V. Porceddu, Jimmy J. Caudell, Shlomo A. Koyfman, Ahmed I Ghanem, Nikhil P. Joshi, Jamie A. Ku, David J. Adelstein, Joseph Scharpf, Neal Dunlap, Brian B. Burkey, Nancy Y. Lee, Jillian Tsai, Neil M. Woody, Brandon Prendes, L. Schwartzman, Arslan Babar, Jessica L. Geiger
Publikováno v:
Current Oncology, Vol 28, Iss 221, Pp 2409-2419 (2021)
Current Oncology
Volume 28
Issue 4
Pages 221-2419
Current Oncology
Volume 28
Issue 4
Pages 221-2419
Adjuvant chemoradiation (CRT), with high-dose cisplatin remains standard treatment for oral cavity squamous cell carcinoma (OCSCC) with high-risk pathologic features. We evaluated outcomes associated with different cisplatin dosing and schedules, con
Autor:
Steven F Mandish, Jeffrey M. Bumpous, Weston Wall, Abbas Rattani, Grant McKenzie, Alyssa Farley, Neal Dunlap, Jeremy Gaskins, Paul Tennant, Mehran Yusuf
Publikováno v:
Annals of Surgical Oncology. 28:6154-6165
e21509 Background: Immunosuppression (IS) is not currently considered in staging for Merkel cell carcinoma (MCC). We performed an analysis of the National Cancer Database (NCDB) to investigate immune status as an independent predictor of overall surv
Autor:
Jeffrey B. Jorgensen, Jeremy Gaskins, M.E. May, Jeffrey M. Bumpous, W. Fisher, Neal Dunlap, Weston Wall, Paul Tennant, Mehran Yusuf, Steven F Mandish
Publikováno v:
Acta Oncologica. 59:1409-1415
Surrogate markers of the host immune response are not currently included in AJCC staging for Merkel cell carcinoma (MCC), and have not been consistently associated with clinical outcomes. We performed an analysis of a large national database to inves
Autor:
M.E. May, W. Fisher, Jeffrey M. Bumpous, Paul Tennant, S. Mandish, Mehran Yusuf, Jeffrey B. Jorgensen, Weston Wall, Neal Dunlap, Jeremy Gaskins
Publikováno v:
Clinical and Translational Oncology. 22:2009-2016
Immunosuppressed (IS) patients are at increased risk for developing Merkel cell carcinoma (MCC) with worsened outcomes compared to immunocompetent (IC) patients. We sought to determine the effects of immune status on the efficacy of adjuvant RT regar
Autor:
Philip Kovoor, Stephen T. Sonis, Kyle Colvett, Jeffrey Mark Brill, Madhur Garg, Neal Dunlap, James Wheeler, Roberto Arevalo-Araujo, Sharon M. Gordon, Francis P. Worden, Abhinand V. Peddada, Matthew Downs, Voichita Bar-Ad, Marcelo Bonomi, Anshu K. Jain, Christopher M. Lee, John M. Buatti, Chaitali Singh Nangia, Carryn M. Anderson, Deborah P. Saunders, Sanford Katz, Jon Holmlund, Amarinthia Curtis, Dukagjin Blakaj, Arielle S. Lee, Sanjiv S. Agarwala, Douglas C. Miller
Publikováno v:
Journal of Clinical Oncology
PURPOSE Oral mucositis (OM) remains a common, debilitating toxicity of radiation therapy (RT) for head and neck cancer. The goal of this phase IIb, multi-institutional, randomized, double-blind trial was to compare the efficacy and safety of GC4419,
Publikováno v:
Radiation Medicine and Protection
Radiation Medicine and Protection, Vol 2, Iss 4, Pp 139-145 (2021)
Radiation Medicine and Protection, Vol 2, Iss 4, Pp 139-145 (2021)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of the coronavirus disease 2019 (COVID-19), has caused more than 179 million infections and 3.8 million deaths worldwide. Global health authorities working on the CO